Metagenomi Therapeutics, Inc.
MGX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001785279
In the last 90 days, Metagenomi Therapeutics, Inc. insiders filed 1 open-market purchase and 3 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $7.45M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Metagenomi Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- +4 vs. Q1 2024
- Shares held
- 12.2M
- −1.15M (−8.6%) vs. Q1 2024
- Total value
- $49.6M
- −$90.7M (−64.7%) vs. Q1 2024
- New holders
- 15
- 15 more added
- Sold out
- 11
- 14 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 43 | $7.45M |
| Q1 2026 | 48 | $8.65M |
| Q4 2025 | 56 | $11.0M |
| Q3 2025 | 58 | $14.2M |
| Q2 2025 | 69 | $10.4M |
| Q1 2025 | 79 | $13.5M |
| Q4 2024 | 77 | $38.8M |
| Q3 2024 | 67 | $25.3M |
| Q2 2024 | 54 | $49.6M |
| Q1 2024 | 50 | $140.3M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Metagenomi Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Larson Financial Group LLC | 50 | $204 | 0.00% | 00.0% | Unchanged |
| Principal Securities, Inc. | 54 | $220 | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 218 | $1.00K | 0.00% | +218 | New |
| California State Teachers Retirement System | 457 | $1.86K | 0.00% | +457 | New |
| Royal Bank of Canada | 603 | $2.00K | 0.00% | +603 | New |
| Legal & General Group Plc | 491 | $2.00K | 0.00% | −9,509−95.1% | Reduced |
| Ameritas Investment Partners, Inc. | 618 | $2.52K | 0.00% | +618 | New |
| Qube Research & Technologies Ltd | 1,053 | $4.30K | 0.00% | −15,614−93.7% | Reduced |
| Citigroup Inc | 1,390 | $5.67K | 0.00% | −15,278−91.7% | Reduced |
| UBS Group AG | 2,158 | $8.80K | 0.00% | +478+28.5% | Added |
| Barclays PLC | 2,166 | $8.84K | 0.00% | +2,166 | New |
| Point72 (DIFC) Ltd | 2,295 | $9.36K | 0.00% | +2,295 | New |
| JPMorgan Chase & Co | 2,689 | $11.0K | 0.00% | −11,058−80.4% | Reduced |
| Bank of America Corp | 3,295 | $13.4K | 0.00% | +146+4.6% | Added |
| Corebridge Financial, Inc. | 3,395 | $13.9K | 0.00% | +3,395 | New |
| Tower Research Capital LLC (TRC) | 4,375 | $17.9K | 0.00% | +3,919+859.4% | Added |
| US Bancorp | 4,500 | $18.4K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 5,440 | $22.0K | 0.00% | +5,440 | New |
| BNP Paribas Arbitrage, SA | 5,543 | $22.6K | 0.00% | +5,543 | New |
| Rhumbline Advisers | 6,423 | $26.2K | 0.00% | +6,423 | New |
| Cerity Partners LLC | 10,000 | $40.8K | 0.00% | +10,000 | New |
| Squarepoint Ops LLC | 10,202 | $41.6K | 0.00% | −16,286−61.5% | Reduced |
| Northern Trust Corp | 13,596 | $55.5K | 0.00% | +543+4.2% | Added |
| Bramshill Investments, LLC | 15,500 | $63.2K | 0.01% | −10,000−39.2% | Reduced |
| XTX Topco Ltd | 16,244 | $66.3K | 0.01% | +16,244 | New |
| Hudson Bay Capital Management LP | 17,000 | $69.4K | 0.00% | −49,666−74.5% | Reduced |
| Wells Fargo & Company | 26,312 | $107.4K | 0.00% | +1,418+5.7% | Added |
| Resolute Partners Group | 26,500 | $108.1K | 0.03% | +16,500+165.0% | Added |
| New York State Common Retirement Fund | 26,600 | $108.5K | 0.00% | +26,600 | New |
| State Street Corp | 30,474 | $124.3K | 0.00% | +30,474 | New |
| Two Sigma Investments, LP | 37,694 | $153.8K | 0.00% | +17,535+87.0% | Added |
| Jacobs Levy Equity Management, Inc | 44,156 | $180.2K | 0.00% | +44,156 | New |
| Morgan Stanley | 44,718 | $182.4K | 0.00% | +35,513+385.8% | Added |
| Charles Schwab Investment Management Inc | 45,111 | $184.1K | 0.00% | +14,963+49.6% | Added |
| Point72 Asset Management, L.P. | 99,002 | $403.9K | 0.00% | −272,098−73.3% | Reduced |
| Geode Capital Management, LLC | 164,235 | $670.1K | 0.00% | +77,472+89.3% | Added |
| Marshall Wace, LLP | 168,639 | $688.0K | 0.00% | −14,388−7.9% | Reduced |
| ExodusPoint Capital Management, LP | 192,763 | $786.0K | 0.01% | −34,793−15.3% | Reduced |
| Vanguard Group Inc | 216,166 | $882.0K | 0.00% | +36,619+20.4% | Added |
| Frazier Life Sciences Management, L.P. | 245,692 | $1.00M | 0.05% | −33,333−11.9% | Reduced |
| Pura Vida Investments, LLC | 270,618 | $1.04M | 1.26% | −190,665−41.3% | Reduced |
| Artal Group S.A. | 300,000 | $1.22M | 0.03% | 00.0% | Unchanged |
| Millennium Management LLC | 313,162 | $1.23M | 0.00% | −434,386−58.1% | Reduced |
| Norges Bank | 360,202 | $1.47M | 0.00% | +252,310+233.9% | Added |
| BlackRock Inc. | 420,242 | $1.71M | 0.00% | +305,918+267.6% | Added |
| Deep Track Capital, LP | 466,232 | $1.90M | 0.06% | 00.0% | Unchanged |
| Sozo Ventures GP II, L.P. | 581,577 | $2.37M | 0.97% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 583,041 | $2.38M | 0.04% | 00.0% | Unchanged |
| Citadel Advisors LLC | 729,852 | $2.93M | 0.00% | +5,951+0.8% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 777,768 | $3.17M | 0.08% | 00.0% | Unchanged |
| PFM Health Sciences, LP | 1,267,002 | $5.17M | 0.28% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 1,343,201 | $5.48M | 0.03% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 1,477,749 | $6.03M | 0.08% | −266,666−15.3% | Reduced |
| Novo Holdings A/S | 1,800,000 | $7.34M | 0.40% | +60,825+3.5% | Added |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −350,859−100.0% | Sold out |
| Altitude Crest Partners Inc. | 0 | $0 | 0.00% | −133,333−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −52,058−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −31,477−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −22,009−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,330−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −952−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −355−100.0% | Sold out |